雷公藤醇
化学
癌症研究
线粒体
免疫疗法
癌症免疫疗法
癌症
癌症治疗
细胞
癌细胞
细胞凋亡
癌细胞系
细胞生物学
肿瘤细胞
下调和上调
细胞生长
细胞培养
癌症治疗
信号转导
作者
Zhe Zhang,Jun Tong,Xiang Cao,Wenyue Xu,Zhikang Qi,Xiuru Kuang,Yongzhuo Huang,Yujing He,Congyan Zeng,Mei Hu,Shiyang Shen
标识
DOI:10.1016/j.cej.2026.175311
摘要
Tumor immunotherapy is a promising cancer treatment strategy, but its efficacy is often constrained by immunosuppressive tumor microenvironment and insufficient innate immune activation. Engaging the cGAS–STING pathway can enhance antitumor immunity and reprogram tumor microenvironment. Celastrol (CEL), a Tripterygium wilfordii-derived monomer, can destabilize mitochondrial membranes and promotes mitochondrial DNA (mtDNA) release, thereby activating the cGAS–STING. However, its lack of mitochondrial accumulation results in modest immunostimulatory activity and limited translational potential. Here, we engineer a mitochondria-targeted, ATP-responsive metal–polyphenol network (CEL/mMPNs) for intratumoral delivery of CEL. Upon triphenylphosphonium-mediated mitochondrial accumulation, high-level ATP triggers in situ CEL release, causing mitochondrial membrane depolarization, mtDNA leakage into the cytoplasm, and robust cGAS–STING activation in cancer cells. These events together drive mitochondria-dependent apoptosis and immunogenic cancer cell death. In animal studies, CEL/mMPNs markedly inhibited tumor growth and converted the tumor microenvironment from “cold” to “hot”, characterized by enhanced tumor antigen presentation and increased cytotoxic T cell infiltration. Moreover, when combined with programmed cell death protein-1 blockade, CEL/mMPNs further suppressed postoperative tumor recurrence, reduced immunosuppressive cell populations, and generated durable immune memory against residual cancer cells. Collectively, these findings identify CEL/mMPNs as a potent platform to augment tumor immunotherapy via mitochondria-driven innate immune activation.
科研通智能强力驱动
Strongly Powered by AbleSci AI